Covid 19 In Alzheimer S Disease And Dementia

COVID-19 in Alzheimer’s Disease and Dementia crucially summarizes the current status of the coronavirus in patients suffering from these conditions, describing why they are a common cause of morbidity among those with COVID-19. The first section includes chapters that provide a general description of COVID-19, including SARS-CoV-2 structure, function, and biology, and its impact on the elderly with chronic conditions include hypertension, diabetes, obesity, kidney disease, respiratory illnesses, and infectious diseases. Also discussed are effects of the virus on the immune system. The second section shifts to the impact of COVID-19 on those with dementia or Alzheimer’s disease, with special emphasis on age, gender, ethnic background, and lifestyle. Bringing this focus on neurodegenerative disease in one comprehensive resource, this volume is an essential reference for neuroscientists, clinicians, biomedical scientists, and all others working or interested in the field. Discusses Alzheimer’s disease and dementia as morbidities for COVID-19 Describes SARS-CoV-2 structure, function, and biology Examines impact on elderly with chronic conditions including hypertension, diabetes, obesity, kidney disease, respiratory illnesses, and infectious diseases Covers the effect of race, gender, and sex as additional risk factors

The Open Access version of this book, available at www.taylorfrancis.com, has been made available under a Creative Commons Attribution-Non Commercial-No Derivatives 4.0 license. This volume presents a range of research approaches to the exploration of ageing during a pandemic situation. One of the first collections of its kind, it offers an array of studies employing research methodologies that lend themselves to replication in similar contexts by those seeking to understand the effects of epidemics on older people. Thematically organised, it shows how to reconcile qualitative and quantitative approaches, thus rendering them complementary, bringing together studies from around the world to offer an international perspective on ageing as it relates to an unprecedented epidemiological phenomenon. As such, it will appeal to researchers in the field of gerontology, as well as sociologists of medicine and clinicians seeking to understand the disruptive effects of the recent coronavirus outbreak on later life.

In this issue, guest editors bring their considerable expertise to this important topic. Provides in-depth reviews on the latest updates in the field, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.

The physical effects of COVID-19 are felt globally. However, one issue that has not been sufficiently addressed is the impact of COVID-19 on mental health. During the COVID-19 pandemic, citizens worldwide are enduring widespread lockdowns; children are out of school; and millions have lost their jobs, which has caused anxiety, depression, insomnia, and distress. Mental Health Effects of COVID-19 provides a comprehensive analysis of mental health problems resulting from COVID-19, including depression, suicidal thoughts and attempts, trauma, and PTSD. The book includes chapters detailing the impact of COVID-19 on the family’s well-being and society dynamics. The book concludes with an explanation on how meditation and online treatment methods can be used to combat the effects on mental health. Discusses family dynamics, domestic violence, and aggression due to COVID-19 Details the psychological impact of COVID-19 on children and adolescents Includes key information on depression, anxiety, and suicide as a result of COVID-19

Nearly 44 million people have Alzheimer’s or related dementia worldwide, according to the Alzheimer’s Disease International organization. That number is expected to double every 20 years. Unlike other books on the market, Alzheimer's Disease: Understanding Biomarkers, Big Data, and Therapy covers recent advancements in cognitive, clinical, neural, and therapeutic aspects of Alzheimer’s and other forms of dementia. First, readers are introduced to cognitive and clinical studies, focusing on the different types of memory impairment, past and future thinking. This includes the prevalence of depression, its relationship to other symptoms, and the quality of life for those with Alzheimer’s disease. In addition, the book discusses recent studies on memory dysfunction in advanced-stage Alzheimer’s disease, in comparison to early-stage, including a chapter on the underlying factors in the transition from mild cognitive impairment to Alzheimer’s diagnosis. Following this section, the book presents recent studies on the role of different cortical and subcortical structures in the development of various symptoms in Alzheimer’s disease, as well as different neural biomarkers underlying the development and treatment of the disease. In the last section of the book, therapeutic aspects of Alzheimer’s disease, focusing on behavioral and pharmacological treatments of sleep disorders, memory problems, and depression, are reviewed. The book aids readers in understanding the advances in research and care, making it a prime tool for all clinicians, psychologists, researchers, neurologists, and caregivers of dementia patients. Reviews recent developments of cognitive and clinical studies Covers factors underlying the transition from mild cognitive impairment to Alzheimer’s disease Discusses different neural biomarkers underlying the development and treatment of Alzheimer’s disease Provides a comparison of the effectiveness of various types of treatments